289 related articles for article (PubMed ID: 27577169)
1. Centromere and kinetochore gene misexpression predicts cancer patient survival and response to radiotherapy and chemotherapy.
Zhang W; Mao JH; Zhu W; Jain AK; Liu K; Brown JB; Karpen GH
Nat Commun; 2016 Aug; 7():12619. PubMed ID: 27577169
[TBL] [Abstract][Full Text] [Related]
2. A specific gene expression signature for visceral organ metastasis in breast cancer.
Savci-Heijink CD; Halfwerk H; Koster J; Horlings HM; van de Vijver MJ
BMC Cancer; 2019 Apr; 19(1):333. PubMed ID: 30961553
[TBL] [Abstract][Full Text] [Related]
3. Cancer-associated alteration of pericentromeric heterochromatin may contribute to chromosome instability.
Slee RB; Steiner CM; Herbert BS; Vance GH; Hickey RJ; Schwarz T; Christan S; Radovich M; Schneider BP; Schindelhauer D; Grimes BR
Oncogene; 2012 Jul; 31(27):3244-53. PubMed ID: 22081068
[TBL] [Abstract][Full Text] [Related]
4. Mislocalization of centromeric histone H3 variant CENP-A contributes to chromosomal instability (CIN) in human cells.
Shrestha RL; Ahn GS; Staples MI; Sathyan KM; Karpova TS; Foltz DR; Basrai MA
Oncotarget; 2017 Jul; 8(29):46781-46800. PubMed ID: 28596481
[TBL] [Abstract][Full Text] [Related]
5. Chromosome 17 centromere amplification and chromosomal instability (CIN) in breast cancer: Pathogenic and therapeutic implications.
Voutsadakis IA
Neoplasma; 2019 Nov; 66(6):859-869. PubMed ID: 31607133
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of centromere 17 copy number gain in breast cancer depends on breast cancer subtype.
Lee K; Jang MH; Chung YR; Lee Y; Kang E; Kim SW; Kim YJ; Kim JH; Kim IA; Park SY
Hum Pathol; 2017 Mar; 61():111-120. PubMed ID: 27989787
[TBL] [Abstract][Full Text] [Related]
7. Analysis of centromere signal patterns in breast cancer cells with chromosomal instability using image cytometry combined with centromere fluorescence in situ hybridization.
Ito H; Oga A; Ikemoto K; Furuya T; Maeda N; Yamamoto S; Kawauchi S; Itoh H; Oka M; Sasaki K
Cytometry A; 2014 Sep; 85(9):809-16. PubMed ID: 25044720
[TBL] [Abstract][Full Text] [Related]
8. A four gene signature predicts benefit from anthracyclines: evidence from the BR9601 and MA.5 clinical trials.
Spears M; Yousif F; Lyttle N; Boutros PC; Munro AF; Twelves C; Pritchard KI; Levine MN; Shepherd L; Bartlett JM
Oncotarget; 2015 Oct; 6(31):31693-701. PubMed ID: 26372731
[TBL] [Abstract][Full Text] [Related]
9. Nuclear accumulation of annexin A2 contributes to chromosomal instability by coilin-mediated centromere damage.
Kazami T; Nie H; Satoh M; Kuga T; Matsushita K; Kawasaki N; Tomonaga T; Nomura F
Oncogene; 2015 Aug; 34(32):4177-89. PubMed ID: 25347736
[TBL] [Abstract][Full Text] [Related]
10. Centromere 17 copy number gain reflects chromosomal instability in breast cancer.
Lee K; Kim HJ; Jang MH; Lee S; Ahn S; Park SY
Sci Rep; 2019 Nov; 9(1):17968. PubMed ID: 31784614
[TBL] [Abstract][Full Text] [Related]
11. Integrated gene expression profile predicts prognosis of breast cancer patients.
Li LF; Xu XJ; Zhao Y; Liu ZB; Shen ZZ; Jin WR; Shao ZM
Breast Cancer Res Treat; 2009 Jan; 113(2):231-7. PubMed ID: 18278552
[TBL] [Abstract][Full Text] [Related]
12. Use of 70-gene signature to predict prognosis of patients with node-negative breast cancer: a prospective community-based feasibility study (RASTER).
Bueno-de-Mesquita JM; van Harten WH; Retel VP; van 't Veer LJ; van Dam FS; Karsenberg K; Douma KF; van Tinteren H; Peterse JL; Wesseling J; Wu TS; Atsma D; Rutgers EJ; Brink G; Floore AN; Glas AM; Roumen RM; Bellot FE; van Krimpen C; Rodenhuis S; van de Vijver MJ; Linn SC
Lancet Oncol; 2007 Dec; 8(12):1079-1087. PubMed ID: 18042430
[TBL] [Abstract][Full Text] [Related]
13. Centromere protein H is up-regulated in primary human colorectal cancer and its overexpression induces aneuploidy.
Tomonaga T; Matsushita K; Ishibashi M; Nezu M; Shimada H; Ochiai T; Yoda K; Nomura F
Cancer Res; 2005 Jun; 65(11):4683-9. PubMed ID: 15930286
[TBL] [Abstract][Full Text] [Related]
14. MYC copy gain, chromosomal instability and PI3K activation as potential markers of unfavourable outcome in trastuzumab-treated patients with metastatic breast cancer.
Gogas H; Kotoula V; Alexopoulou Z; Christodoulou C; Kostopoulos I; Bobos M; Raptou G; Charalambous E; Tsolaki E; Xanthakis I; Pentheroudakis G; Koutras A; Bafaloukos D; Papakostas P; Aravantinos G; Psyrri A; Petraki K; Kalogeras KT; Pectasides D; Fountzilas G
J Transl Med; 2016 May; 14(1):136. PubMed ID: 27184134
[TBL] [Abstract][Full Text] [Related]
15. Eukaryotic translation initiation factor 4E (eIF4E) expression is associated with breast cancer tumor phenotype and predicts survival after anthracycline chemotherapy treatment.
Heikkinen T; Korpela T; Fagerholm R; Khan S; Aittomäki K; Heikkilä P; Blomqvist C; Carpén O; Nevanlinna H
Breast Cancer Res Treat; 2013 Aug; 141(1):79-88. PubMed ID: 23974830
[TBL] [Abstract][Full Text] [Related]
16. Combined evaluation of centromere protein H and Ki-67 as prognostic biomarker for patients with gastric carcinoma.
He WL; Li YH; Yang DJ; Song W; Chen XL; Liu FK; Wang Z; Li W; Chen W; Chen CY; He YL; Zhan WH
Eur J Surg Oncol; 2013 Feb; 39(2):141-9. PubMed ID: 22999412
[TBL] [Abstract][Full Text] [Related]
17. Genome-wide chromosomal instability by cell-free DNA sequencing predicts survival in patients with metastatic breast cancer.
Mo H; Wang X; Ma F; Qian Z; Sun X; Yi Z; Guan X; Li L; Liu B; Xu B
Breast; 2020 Oct; 53():111-118. PubMed ID: 32738630
[TBL] [Abstract][Full Text] [Related]
18. Clinical Implications of Chromosomal Instability (CIN) and Kinetochore Abnormalities in Breast Cancers.
Voutsadakis IA
Mol Diagn Ther; 2019 Dec; 23(6):707-721. PubMed ID: 31372940
[TBL] [Abstract][Full Text] [Related]
19. Targeting chromosomal instability and tumour heterogeneity in HER2-positive breast cancer.
Burrell RA; Juul N; Johnston SR; Reis-Filho JS; Szallasi Z; Swanton C
J Cell Biochem; 2010 Nov; 111(4):782-90. PubMed ID: 20665662
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of Ran GTPase Components Regulating Nuclear Export, but not Mitotic Spindle Assembly, Marks Chromosome Instability and Poor Prognosis in Breast Cancer.
Vaidyanathan S; Thangavelu PU; Duijf PH
Target Oncol; 2016 Oct; 11(5):677-686. PubMed ID: 27023921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
